These Analysts Boost Their Forecasts On Tenet Healthcare After Upbeat Q2 Results
THC's positive earnings and guidance upgrades typically lead to stock appreciation, akin to past quarters where results led to significant bullish sentiment.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
THC's positive earnings and guidance upgrades typically lead to stock appreciation, akin to past quarters where results led to significant bullish sentiment.
What happened, with direct paths to the underlying reporting
THC surpassed earnings expectations with $4.02 per share, beating $2.87 estimate. Sales reached $5.271 billion, exceeding the $5.161 billion forecast. FY2025 EPS guidance raised to $15.55-$16.21 from $11.99-$13.12. Analysts upgraded price targets, boosting confidence in THC's performance. Stock rose 1% to $157.49 following positive earnings announcements.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.